Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula

This study has been completed.
Sponsor:
Information provided by:
Mead Johnson Nutrition
ClinicalTrials.gov Identifier:
NCT01205659
First received: September 17, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose

Allergy and Asthma study of children (3 - 7 Years of age) who participated in randomized trials of supplemented infant formula during infancy conducted by The Retina Foundation of the Southwest .


Condition
Allergy and Asthma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Allergy and Asthma in Children Who Were Fed Supplemented Infant Formula (3-7 Years of Age)

Resource links provided by NLM:


Further study details as provided by Mead Johnson Nutrition:

Primary Outcome Measures:
  • Prevalence of asthma and allergy related diagnosis in medical records for ages 3 - 7 years

Secondary Outcome Measures:
  • Prevalence of Serious Adverse Events in medical records
  • Long-term growth

Study Start Date: December 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   3 Years to 7 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

Children who participated in randomizaed trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy

Criteria

Inclusion Criteria:

  • Children who participated in randomized trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01205659

Locations
United States, Texas
The Retina Foundation of The Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson Nutrition
  More Information

No publications provided

Responsible Party: Eileen Birch, The Retina Foundation of the Southwest
ClinicalTrials.gov Identifier: NCT01205659     History of Changes
Other Study ID Numbers: 8611
Study First Received: September 17, 2010
Last Updated: September 17, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypersensitivity
Asthma
Immune System Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on July 28, 2014